In situ analyses of genome instability in breast cancer
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Transition through telomere crisis is thought to be a crucial event in the development of most breast carcinomas. Our goal in this study was to determine where this occurs in the context of histologically defined breast cancer progression. To this end, we assessed genome instability (using fluorescence in situ hybridization) and other features associated with telomere crisis in normal ductal epithelium, usual ductal hyperplasia, ductal carcinoma in situ and invasive cancer. We modeled this process in vitro by measuring these same features in human mammary epithelial cell cultures during ZNF217-mediated transition through telomere crisis and immortalization. Taken together, the data suggest that transition through telomere crisis and immortalization in breast cancer occurs during progression from usual ductal hyperplasia to ductal carcinoma in situ.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An analysis of genome instability and other features associated with telomere crisis, including anaphase and chromatin bridges, suggests that transition through telomere crisis in breast cancer occurs during progression from usual ductal hyperplasia (UDH) to ductal carcinoma in situ (DCIS)145.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [145]
In the citing paper
“Short telomeres and a sharp increase in genome instability are observed in the early stages of breast cancer before telomerase activation and genome stabilization [353].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [353]
In the citing paper
“telomeres were shown to be shorter in invasive cancers Telomeres and telomerase in cancer of the breast, prostate and pancreas, as well as in their pre-invasive counterparts (123-126).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [124]
In the citing paper
“Recent observations indicate that both telomere dysfunction73, 74 and the DDR75, 76 are activated at the earliest stages in many human carcinomas.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [73]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829 · cited 1×
“This may explain why the risk of developing invasive cancer in individuals with UDH is only modestly increase”
BackgroundTelomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Assembly of microarrays for genome-wide measurement of DNA copy number
Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., et al. (2001) · Nature Genetics · doi:10.1038/ng754 · Cited by 999 · cited 1×
“We analyzed genome copy-number changes using array CGH as described previousl”
MethodSelf-citationRegulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 798 · cited 1×
“Most epithelial cells lack active telomerase, and so extended proliferation leads to telomere erosion and, eventually, loss of telomere functio”
BackgroundConnecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561 · cited 1×
“The molecular events that enable normal epithelial cells to progress to invasive, metastatic disease are increasingly well understoo”
BackgroundNormal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., & Tlsty, T. D. (2001) · Nature · doi:10.1038/35054579 · Cited by 560
Self-citationERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., & Gray, J. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5321 · Cited by 555
Self-citationTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“and are almost always eliminated by damage-surveillance mechanism”
Background
Cited by
Items 201–300 of 361
González‐Moles, M. Á., Warnakulasuriya, S., López-Ansio, M., & Ramos‐García, P. (2022) · Cancers · doi:10.3390/cancers14153834 · Cited by 28
“oncogenesis has allowed tumour cells to survive and expand clonally, while the lack of telomerase activity at early stages of oncogenesis allows mutations linked to telomere shortening and chromosomal instability to be acquired [204,205].”
BackgroundSilva, A. G. D. S., Graves, H. A., Guffei, A., Ricca, T. I., Mortara, R. A., Jasiulionis, M. G., & Mai, S. (2010) · Neoplasia · doi:10.1593/neo.91004 · Cited by 29
Ross, A. D. M., Cook, M. G., Chong, H., Hossain, M., Pandha, H., & Bennett, D. C. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12060 · Cited by 32
“…Hardev S. Pandha and Dorothy C. Bennett Submit your next paper to PCMR online at http://mc.manuscriptcentral.com/pcmr DOI: 10.1111/pcmr.12060 Volume 26, Issue 2, Pages 226–235 Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression”
InfluentialZhou, X., Meeker, A. K., Makambi, K. H., Kosti, O., Kallakury, B., Sidawy, M. K., Loffredo, C. A., & Zheng, Y.-L. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr248 · Cited by 28
Reddy, V., Wu, M., Ciavattone, N. G., McKenty, N. T., Menon, M., Barrack, E. R., Reddy, G. P. V., & Kim, S.-H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.671404 · Cited by 25
“Genomic instability is a salient feature of cancers (10, 11) and it underlies the biological differences between indolent and aggressive prostate cancers (12).”
BackgroundVargas-Rondón, N., Pérez-Mora, E., Villegas, V. E., & Rondón‐Lagos, M. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0028 · Cited by 23
Hayward, M.-K., Allen, M. D., Gomm, J. J., Goulding, I., Thompson, C. L., Knight, M. M., Marshall, J. F., & Jones, J. L. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00464-4 · Cited by 25
Zheng, Y., Zhou, X., Loffredo, C. A., Shields, P. G., & Sun, B. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq461 · Cited by 27
Debatisse, M., & Malfoy, B. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_12 · Cited by 25
“Indeed, several studies strongly suggest that telomere dysfunction triggers gross genome remodelling through reiterated cycles of BFB, and promotes progression of various types of human cancers from benign to malignant forms ( Chin et al., 2004; Gisselsson et al., 2004; Hoglund et al., 2003; O'Sullivan et al., 2002).”
BackgroundTelomere Shortening and Fusions: A Link to Aneuploidy in Early Human Embryo Development
Kohlrausch, F. B., Wang, F., Chamani, I. J., & Keefe, D. L. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000907 · Cited by 24
Johnson, J. E., Gettings, E. J., Schwalm, J., Pei, J., Testa, J. R., Litwin, S., von Mehren, M., & Broccoli, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1133 · Cited by 25
“have explored the relationship between genome instability and telomerase activation, including recent work using a human breast cancer model system (23).”
MethodTelomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes
Bazarov, A. V., Hines, W. C., Mukhopadhyay, R., Beliveau, A., Melodyev, S., Zaslavsky, Y., & Yaswen, P. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9856 · Cited by 21
Self-citationSelective pressures for and against genetic instability in cancer: a time-dependent problem
Komarova, N. L., Sadovsky, A. V., & Wan, F. Y. M. (2007) · Journal of The Royal Society Interface · doi:10.1098/rsif.2007.1054 · Cited by 23
Patra, S., Naik, P. P., Mahapatra, K. K., Alotaibi, M. R., Patil, S., Patro, B. S., Sethi, G., Efferth, T., & Bhutia, S. K. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216843 · Cited by 23
Zubeldia-Plazaola, A., Recalde‐Percaz, L., Moragas, N., Alcaraz, M., Chen, X., Mancino, M., Fernández‐Nogueira, P., de Puig, M. P., Guzmán, F., Noguera‐Castells, A., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0977-z · Cited by 20
“Recent efforts have focused on unravelling the role of cancerous epithelial cells in DCIS and IDC [4, 7].”
BackgroundWren, B. G. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31803816db · Cited by 20
“The fourth alteration to cell behavior leading to cancer involves the autonomous program that limits the number of times that a cell is allowed to divide.(5,39,40) Normal cells are programmed to reproduce a finite number of times before loss of terminal telomeres leads to end-”
BackgroundChromosomal instability and cancer: not just one CINgle mechanism
Boland, C. R., Komarova, N. L., & Goel, A. (2009) · Gut · doi:10.1136/gut.2008.160143 · Cited by 20
“breast cancers initially increases, reaches a peak, and then decreases in later stages.(8) A mathematical analysis suggests that the optimal strategy for cancer consists of a high level of CIN at the beginning followed by stabilization at later stages.”
BackgroundPrecancer: Sequentially Acquired or Predetermined?
Cardiff, R. D., & Borowsky, A. D. (2009) · Toxicologic Pathology · doi:10.1177/0192623309356447 · Cited by 20
“It seems equally possible that changes might occur in the developing duct in childhood and during puberty and that these changes might indicate an ‘‘at-risk’’ branch of the mammary tree, but the changes occurred well prior to the onset of DCIS and are not causal.”
BackgroundInfluentialThe number of dysfunctional telomeres in a cell: one amplifies; more than one translocate
Tusell, L., Soler, D., Agostini, M., Pampalona, J., & Genescà, A. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167818 · Cited by 22
“It has been observed that the genomic changes occurring in HMEC cultures before and during immortalization are remarkably similar to those occurring in breast cancer during progression from usual ductal hyperplasia to ductal carcinoma in situ (Chin et al., 2004).”
BackgroundThe Relative Timing of Mutations in a Breast Cancer Genome
Newman, S., Howarth, K., Greenman, C., Bignell, G. R., Tavaré, S., & Edwards, P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064991 · Cited by 19
“Others favor a transient period of chromosome instability, either at ‘crisis’ caused by telomere loss, or at some other catastrophic event such as ‘chromothripsis’, in which one or more chromosomes undergo massive rearrangement, apparently in a single event [9,10].”
BackgroundSomeya, M., Sakata, K.-I., Matsumoto, Y., Kamdar, R. P., Kai, M., Toyota, M., & Hareyama, M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.158 · Cited by 21
“It also prompts the loss or activation of a number of critical genes, such as those involved in cell proliferation, differentiation, and apoptosis (Nishizaki et al, 1997; Maser and DePinho, 2002; Chin et al, 2004; Hezel et al, 2006).”
BackgroundCell Fusion In Tumor Development: Accelerated Genetic Evolution
Harkness, T., Weaver, B. A. A., Alexander, C. M., & Ogle, B. M. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.30 · Cited by 20
Ory, V., Tassi, E., Cavalli, L. R., Sharif, G. M., Sáenz, F., Baker, T. M., Schmidt, M. O., Mueller, S. C., Furth, P. A., Wellstein, A., et al. (2013) · Oncogene · doi:10.1038/onc.2013.263 · Cited by 20
A tool for the quantitative spatial analysis of complex cellular systems
Fernández‐González, R., Barcellos‐Hoff, M. H., & Ortíz-de-Solórzano, C. (2005) · IEEE Transactions on Image Processing · doi:10.1109/tip.2005.852466 · Cited by 19
Recent Advances in Tumor Targeting Approaches
Thanki, K., Kushwah, V., & Jain, S. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_2 · Cited by 19
“A variety of mediators have been known which actually bridge the gap between dysregulation of cell cycle and genomic instability such as telomere crisis [ 77 ].”
BackgroundSchumacher, S., Bartenhagen, C., Hoffmann, M., Will, D., Fischer, J., Baldus, S. E., Vay, C., Fluegen, G., Dizdar, L., Vallböhmer, D., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.233 · Cited by 18
“It is generally accepted that higher numbers of alterations are directly linked to CIN (Thompson et al, 2010; Nicholson and Cimini, 2015), to disease progression (Chin et al, 2004; Li et al, 2014) and increased genomic heterogeneity (Jamal-Hanjani et al, 2017).”
BackgroundSpontaneous Immortalization of Human Epidermal Cells with Naturally Elevated Telomerase
Rea, M. A., Zhou, L., Qin, Q., Barrandon, Y., Easley, K., Gungner, S. F., Phillips, M. A., Holland, W. S., Gumerlock, P. H., Rocke, D. M., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700424 · Cited by 18
“Current models of the evolution of common human neoplasms such as breast cancer (Chin et al., 2004) have genomic instability, leading to chromosomal aberrations, participating in their early development.”
Microenvironmental Control of the Breast Cancer Cell Cycle
Guo, X., Wu, Y., Hathaway, H. J., & Hartley, R. S. (2012) · The Anatomical Record · doi:10.1002/ar.22417 · Cited by 18
Klein, C. A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.09.035 · Cited by 17
“This observation is puzzling as chromosomal aberrations are acquired before the invasive stage of local progression.(34) However, we could confirm by identification of small allelic losses that most of these genomically normal-appearing cytokeratin-positive cells are of cancerous origin.”
BackgroundFISHtrees 3.0: Tumor Phylogenetics Using a Ploidy Probe
Gertz, E. M., Chowdhury, S. A., Lee, W.-J., Wangsa, D., Heselmeyer‐Haddad, K., Ried, T., Schwartz, R. S., & Schäffer, A. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158569 · Cited by 18
“For example, Chin and colleagues proposed that telomere crisis is what drives the transition from DCIS to IDC [62].”
BackgroundIntratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence
Sinha, V. C., & Piwnica-Worms, H. M. (2018) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-018-9410-6 · Cited by 17
“These findings suggest even at relatively low genetic resolution that underlying genomic instability (which presumably drives heterogeneity) may already be in place in DCIS [74].”
Argilla, D., Chin, K., Singh, M., Hodgson, J. G., Bosenberg, M., Ortíz-de-Solórzano, C., Lockett, S. J., DePinho, R. A., Gray, J. W., & Hanahan, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.032 · Cited by 19
Self-citationGonzález, L. O., González‐Reyes, S., Junquera, S., Marín, L., González, L. O., del Casar, J. M., González, J. M., & Vizoso, F. J. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0782-2 · Cited by 20
MYC amplification and TERT expression in breast tumor progression
Böðvarsdóttir, S. K., Steinarsdóttir, M., Hilmarsdóttir, H., Jonasson, J. G., & Eyfjord, J. E. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.04.002 · Cited by 16
Rao, Y., Xiong, W., Liu, H., Jia, C., Zhang, H., Cui, Z., Zhang, Y., & Cui, J. (2014) · Breast Cancer · doi:10.1007/s12282-014-0553-z · Cited by 15
Genomic instability demonstrates similarity between DCIS and invasive carcinomas
Heaphy, C. M., Bisoffi, M., Joste, N. E., Baumgartner, K. B., Baumgartner, R., & Griffith, J. K. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0165-4 · Cited by 20
“A significant cause of genomic instability is telomere dysfunction [4–7].”
BackgroundGoldstein, N. S., Kestin, L. L., & Vicini, F. A. (2007) · American Journal of Clinical Pathology · doi:10.1309/yu37dvcufuhp8vpy · Cited by 15
Remodeling of Adhesion Network within Cancer Spheroids via Cell–Polymer Interaction
Cho, Y., Yu, S. J., Kim, J., Ko, U. H., Park, E. Y., Choung, J. S., Choi, G., Kim, D., Lee, E., Im, S. G., et al. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00977 · Cited by 18
Multiscalein situanalysis of the role of dyskerin in lung cancer cells
Fernandez‐Garcia, I., Marcos, T. K., Muñoz‐Barrutia, A., Serrano, D., Pío, R., Montuenga, L. M., & Ortíz-de-Solórzano, C. (2012) · Integrative Biology · doi:10.1039/c2ib20219k · Cited by 14
Telomere Length Is Predictive of Breast Cancer Risk inBRCA2Mutation Carriers
Þorvaldsdóttir, B., Aradóttir, M., Stefánsson, Ó. A., Böðvarsdóttir, S. K., & Eyfjord, J. E. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0946 · Cited by 18
“Telomere shortening has been shown to be an early and common molecular alteration in epithelial cancers (14, 15), including breast cancers (16).”
BackgroundKroupa, M., Rachakonda, S. P., Vymetalkova, V. P., Tomášová, K., Liška, V., Vodenková, S., Čumová, A., Rössnerová, A., Vodičková, Ľ., Hemminki, K., et al. (2020) · Mutagenesis · doi:10.1093/mutage/geaa030 · Cited by 17
Escoffier, E., Rezza, A., de Climens, A. R., Belleville, A., Gazzolo, L., Gilson, É., & Dodon, M. D. (2005) · Retrovirology · doi:10.1186/1742-4690-2-77 · Cited by 19
“In human cells, a burst of telomere instability could also favor tumor formation [21,24-27].”
BackgroundTumor viruses and replicative immortality – Avoiding the telomere hurdle
Chen, X., Kamranvar, S. A., & Masucci, M. G. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.006 · Cited by 16
He, W., Luo, S., Huang, T., Ren, J., Wu, X., Shao, J., & Zhu, Q. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0773-7 · Cited by 13
“Genomic instability is a hallmark of carcinogenesis in human solid tumors, including sporadic and familial breast cancer [7–9], which promotes a wide range of mutations, including chromosome deletions, gene amplifications, translocations and polyploidy.”
Wen, V. W., Wu, K., Baksh, S., Hinshelwood, R. A., Lock, R. B., Clark, S. J., Moore, M. A. S., & MacKenzie, K. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0979 · Cited by 14
“[10]/119-145, XXXX, Y, Y, add(1)(q12), del(1)(q12),”
Parmar, H. R., Melov, S., Samper, E., Ljung, B., Cunha, G. R., & Benz, C. C. (2005) · The Breast · doi:10.1016/j.breast.2005.02.004 · Cited by 16
Self-citationIrradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53
Ghaleb, A. M., Yallowitz, A. R., & Marchenko, N. D. (2019) · Communications Biology · doi:10.1038/s42003-019-0669-y · Cited by 15
Telomere Crisis Shapes Cancer Evolution
Nassour, J., & Karlseder, J. (2025) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041688 · Cited by 20
Shekhani, M. T., Barber, J. R., Bezerra, S. M., Heaphy, C. M., González-Roibón, N., Taheri, D., Reis, L. O., Güner, G., Joshu, C. E., Netto, G. J., et al. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.03.015 · Cited by 15
“Many epithelial somatic tumors display short telomeres and increased telomerase [4–8].”
BackgroundThe role of telomere shortening in carcinogenesis: A hybrid stochastic-deterministic approach
Rodriguez-Brenes, I. A., Komarova, N. L., & Wodarz, D. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.09.003 · Cited by 15
Fighting diagnostic and therapeutic nihilism in the elderly with cancer
Biskup, E. M., Vetter, M. H. F., & Wedding, U. (2019) · Annals of Palliative Medicine · doi:10.21037/apm.2019.08.03 · Cited by 14
“Many neoplasms are associated with shortened telomeres, for example in the pancreas, the bones, the prostate and bladder, the lungs, the kidneys, the head and neck (20-22).”
BackgroundQuantitative Image Analysis in Mammary Gland Biology
Fernández‐González, R., Barcellos‐Hoff, M. H., & Ortíz-de-Solórzano, C. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-004-1405-9 · Cited by 12
Telomere erosion in NF1 tumorigenesis
Jones, R. E., Grimstead, J. W., Sedani, A., Baird, D. M., & Upadhyaya, M. (2017) · Oncotarget · doi:10.18632/oncotarget.16981 · Cited by 12
“Such genomic instability is found in human breast cancers, where short telomeres are implicated in the progression from benign ductal carcinoma to malignant ductal carcinoma [46,47,28], and are also observed in several hematological cancers [48].”
BackgroundZNF217: the cerberus who fails to guard the gateway to lethal malignancy.
Li, Y., Wu, H., Wang, Q., & Xu, S. (2021) · PubMed · Cited by 15
Telomere Uncapping, Chromosomes, and Carcinomas
Batista, L. F. Z., & Artandi, S. E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.006 · Cited by 13
“Indeed, analyses of human breast cancer by comparative genome hybridization (CGH) revealed that gene copy number aberrations increased substantially at the ductal carcinoma in situ stage and that telomeres shortened during stepwise progression of human breast cancer (Chin et al., 2004).”
BackgroundStojadinovic, A., Summers, T. A., Eberhardt, J. S., Cerussi, A. E., Grundfest, W. S., Peterson, C. M., Brazaitis, M. P., Krupinski, E. A., & Freeman, H. P. (2011) · Journal of Cancer · doi:10.7150/jca.2.210 · Cited by 11
Immunohistochemical analysis of Ku70/86 expression of breast cancer tissues
Someya, M., Sakata, K., Matsumoto, Y., Satoh, M., Narimatsu, H., & Hareyama, M. (2007) · Oncology Reports · doi:10.3892/or.18.6.1483 · Cited by 11
“Genetic instability prompted the loss or activation of a number of critical genes, such as those involved in cell proliferation, differentiation, and apoptosis (16-19).”
Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma
Wu, D., Zhang, G., Ma, J., Wu, H.-F., Xiong, J., Huang, X., Tian, Y., Deng, T., Han, X., Sun, X., et al. (2021) · Journal of Oncology · doi:10.1155/2021/1301671 · Cited by 10
Heregulin, a new regulator of telomere length in human cells
Menéndez, J. A., Rubio, M. A., Campisi, J., & Lupu, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4964 · Cited by 9
“, ductal carcinoma in situ) as well as in focal areas of histologically-normal epithelium, where breast carcinoma is thought to arise [57, 58].”
BackgroundDomínguez, D., Feijoo, P., Bernal, A., Ercilla, A., Agell, N., Genescà, A., & Tusell, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4958 · Cited by 9
“For this reason, we used the human mammary epithelial cell model (HMEC), which mimics in vitro the genomic events driving malignant progression in the breast [18, 19].”
MethodEscape from Cellular Senescence Is Associated with Chromosomal Instability in Oral Pre-Malignancy
Prime, S. S., Cirillo, N., & Parkinson, E. K. (2023) · Biology · doi:10.3390/biology12010103 · Cited by 11
Mutational profiling of micro-dissected pre-malignant lesions from archived specimens
Nachmanson, D., Steward, J., Yao, H., Officer, A., Jeong, E., O’Keefe, T. J., Hasteh, F., Jepsen, K., Hirst, G. L., Esserman, L. J., et al. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00820-y · Cited by 8
The telomere complex and the origin of the cancer stem cell
Torres-Montaner, A. (2021) · Biomarker Research · doi:10.1186/s40364-021-00339-z · Cited by 9
Accumulation of neutral mutations in growing cell colonies with competition
Sorace, R., & Komarova, N. L. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.08.015 · Cited by 9
“On the other hand, in phase (d), the cells were in a state similar to a telomere-based crisis [34].”
BackgroundBernal, A., Zafon, E., Domínguez, D., Bertran, E., & Tusell, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072078 · Cited by 10
“In the breast, short telomeres and widespread genomic instability can first be observed in premalignant lesions such as ductal carcinoma in situ (DCIS) [20,22], a stage where the p53 and Rb pathways are usually inactivated [63–65], suggesting that these lesions develop from cells expressing insufficient telomerase for…”
BackgroundClinical Relevance of Matrix Metalloproteases and their Inhibitors in Breast Cancer
(2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s13-004 · Cited by 8
“Performing molecular profiling studies comparing DCIS and IDC could be a great approach to assess cancer progress, although several studies failed to identify tumor-stagespecific signatures [92-95].”
BackgroundCho, E. K. (2011) · Journal of Lung Cancer · doi:10.6058/jlc.2011.10.2.77 · Cited by 7
“Ongoing genomic instability results in heterogeneity that is not detectable by CGH and is best assessed by techniques that examine individual cells (41).”
BackgroundWark, L., Novak, D. J., Sabbaghian, N., Amrein, L., Jangamreddy, J. R., Cheang, M., Pouchet, C., Aloyz, R. S., Foulkes, W. D., Mai, S., et al. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22045 · Cited by 8
“Indeed, it seems that telomere crisis, when cells lose telomere function as a result of extended proliferation in the absence of telomerase, is a critical rate limiting and promoting event in the progression of breast carcinogenesis (Chin et al., 2004).”
BackgroundBreast Tissue Biology Expands the Possibilities for Prevention of Age-Related Breast Cancers
Fresques, T., Zirbes, A., Shalabi, S., Samson, S., Preto, S., Stampfer, M. R., & LaBarge, M. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00174 · Cited by 7
“Telomerase reactivation, which confers immortality, is thought to occur during the pre-malignant ductal carcinoma in situ (DCIS) stage of breast cancer progression (Chin et al., 2004; Meeker et al., 2004).”
BackgroundSelf-citationHeregulin, a new interactor of the telosome/shelterin complex in human telomeres
Menéndez, J. A., Benboudjema, L., Vellón, L., Rubio, M. A., Espinoza, I. C., Campisi, J., & Lupu, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4962 · Cited by 7
“As an illustration, we now know that transition through telomere crisis and immortalization is a crucial event in BC that occurs during progression from typical ductal hyperplasia to pre-invasive ductal carcinoma in situ (DCIS), as well as in focal areas of histologicallynormal epithelium from which breast carcinoma i…”
BackgroundFastest Time to Cancer by Loss of Tumor Suppressor Genes
Sanchez‐Tapia, C., & Wan, F. Y. M. (2014) · Bulletin of Mathematical Biology · doi:10.1007/s11538-014-0027-7 · Cited by 8
“However, faster times to target is possible if we allow u to be a function of time as evident from clinical observations of Chin et al. (2004) and Rudolph et al. (2001) and the mathematical results of Wan et al.”
InfluentialSomeya, M., Sakata, K., Matsumoto, Y., Tauchi, H., Narimatsu, H., & Hareyama, M. (2007) · Oncology Reports · doi:10.3892/or.18.4.873 · Cited by 8
Suarez, C. D., Wu, J., Badve, S., Sparano, J. A., Kaliney, W. J., & Littlepage, L. E. (2017) · Oncotarget · doi:10.18632/oncotarget.19308 · Cited by 6
“ZNF217 overexpression also increased the numbers of mitotic cells and anaphase bridges, a marker of genomic instability, in cultured cells [26].”
BackgroundFonti, C., Saumet, A., Abi‐Khalil, A., Orsetti, B., Cleroux, E., Bender, A., Dumas, M., Schmitt, E., Colinge, J., Jacot, W., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32413 · Cited by 7
González‐Ruiz, I., Samayoa‐Descamps, V., Guagua-Cortez, K. A., González‐Moles, M. Á., & Ramos‐García, P. (2025) · Cancers · doi:10.3390/cancers17152427 · Cited by 6
“…OSCC and linked to resistance to apoptosis and genomic stabilization in advanced stages; nevertheless, most of the available evidence on this hallmark originates from studies conducted in oral cancer and other malignant neoplasms [15,97,98], which are beyond the scope of the present scoping review.”
Torres-Montaner, A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45090478 · Cited by 5
“Therefore, the carcinoma in situ stage, a typical feature of common adult cancers, seems to be reached at a critical threshold of telomere erosion [2].”
BackgroundTargeting Telomerase in Hematologic Malignancy
Maritz, M. F., Napier, C. E., Wen, V. W., & MacKenzie, K. L. (2010) · Future Oncology · doi:10.2217/fon.10.42 · Cited by 5
“Chromatids that are joined by telomere fusions break unevenly during mitosis and give rise to abnormal chromosome structures and drive genetic instability [20–22].”
BackgroundCellular replication limits in the Luria–Delbrück mutation model
Rodriguez-Brenes, I. A., Wodarz, D., & Komarova, N. L. (2016) · Physica D Nonlinear Phenomena · doi:10.1016/j.physd.2016.04.007 · Cited by 5
Multistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Ouyang, X., Barling, A. N., Gallegos, J. R., Liu, Y., & Medler, T. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02218-2 · Cited by 5
Shortened Telomeres: A Driving Force Behind Leukemia?
Pepper, C. J., & Baird, D. M. (2010) · Future Oncology · doi:10.2217/fon.10.135 · Cited by 6
“Higher frequency of anaphase bridging has been documented at the adenoma/hyperplasia–carcinoma transition in several solid tumor types [15,23,24], this transition point is also characterized by the upregulation of telomerase [7,25].”
BackgroundChromosomal instability in the lymphocytes of breast cancer patients
Sambyal, V., Kaur, H., Kaur, M., Nitika, S., Meena, S., Uppal, M., Yamini, Y., & Batra, A. P. S. (2009) · Indian journal of human genetics · doi:10.4103/0971-6866.50864 · Cited by 5
“[15] Frequency of allelic imbalance (or MIN) in tumor tissue has been shown to be significantly correlated with tumor progression in colorectal cancer.”
BackgroundSystems Biology Approaches to Decoding the Genome of Liver Cancer
Lee, J., Kim, J. H., Park, Y., & Mills, G. B. (2011) · Cancer Research and Treatment · doi:10.4143/crt.2011.43.4.205 · Cited by 4
“For example, associations of DNA copy-number aberrations with prognosis have been found for a variety of tumor types, including prostate cancer, breast cancer, gastric cancer, multiple myeloma, lymphomas, and HCC [57-62].”
BackgroundIdentification and Use of Personalized Genomic Markers for Monitoring Circulating Tumor DNA
Chen, Y., George, A. M., Olsson, E., & Saal, L. H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7778-9_17 · Cited by 4
Telomere Maintenance and Genome Stability
Hernandez-Sanchez, W. M., Xu, M., & Taylor, D. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00021-5 · Cited by 5
Someya, M., Hasegawa, T., Hori, M., Matsumoto, Y., Nakata, K., Masumori, N., & Sakata, K. (2016) · Journal of Radiation Research · doi:10.1093/jrr/rrw099 · Cited by 5
Remodeling the Irradiated Tumor Microenvironment: The Fifth R of Radiobiology?
Barcellos‐Hoff, M. H. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-40854-5_6 · Cited by 8
Frech, M. S., Jones, L. P., & Furth, P. A. (2005) · Breast Cancer Online · doi:10.1017/s1470903105003135 · Cited by 4
“Loss of genetic stability has been described in human DCIS lesions [37,41].”
BackgroundNeoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients
Eyüboğlu, İ. P., Koca, S., Çelik, B., Amuran, G. G., Uğurlu, M. Ü., Alan, Ö., Telli, T. A., Yumuk, P. F., & Akkіprіk, M. (2024) · International Journal of Breast Cancer · doi:10.1155/2024/6117394 · Cited by 3
Giulietti, M., Piva, F., Cecati, M., Maggio, S., Guescini, M., Saladino, T., Scortichini, L., Crocetti, S., Caramanti, M., Battelli, N., et al. (2024) · Cells · doi:10.3390/cells13060479 · Cited by 5
“Indeed, cancer progression depends on the heterogeneous genetic mutations that occurred in the cells [3,4] and the interactions, not yet well characterized, between tumor epithelial cells and cells comprising the microenvironment (myoepithelial and endothelial cells, fibroblasts, myofibroblasts,…”
Bernal, A., Moltó‐Abad, M., Domínguez, D., & Tusell, L. (2018) · Oncotarget · doi:10.18632/oncotarget.25502 · Cited by 6
“ALT-pathway – Alternative Lengthening of Telomeres pathway BFB – Breakage Fusion Bridge BrdU – 5-bromo-2’deoxyUridine CDKN2A – Cycling Dependent Kinase Inhibitor 2A CIN – Chromosome INstability DAPI – 4′,6-diamidino-2-phenylindole DCIS – Ductal Carcinoma In Situ DDR – DNA Damage Response DOX – Doxycycline DSB – Double…”
BackgroundKwiatkowska, K. M., Anticoli, S., Salvioli, S., Calzari, L., Gentilini, D., Albano, C., Prinzio, R. R. D., Zaffina, S., Carsetti, R., Ruggieri, A., et al. (2024) · Vaccines · doi:10.3390/vaccines12080880 · Cited by 3
“Telomere shortening occurs with aging and is associated with several pathological health conditions and diseases [27–31], therefore a longer telomere length (TL) should be associated with a younger age.”
BackgroundBiology of DCIS and Progression to Invasive Disease
Jansen, S. A. (2012) · Medical radiology · doi:10.1007/174_2012_647 · Cited by 3
“This heterogeneity could be explained by several possible mechanisms, including genomic instability due to telomere shortening, epigenetic instability, malignant stem cells, or phenotypic plasticity (Chin et al. 2004; Marusyk and Polyak 2010).”
BackgroundKumar, B. (2014) · Springer eBooks · doi:10.1007/978-81-322-0843-3_4 · Cited by 5
“1 Genome instability measured during breast tumor progression using FISH [ 206 ].”
BackgroundMethodTelomere Structural Dynamics in Genome Integrity Control and Carcinogenesis
Greenberg, R. A., & Rudolph, K. L. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_11 · Cited by 3
Collisson, E. A., & Cho, R. J. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0393 · Cited by 3
Genetic Instability in Cancer: An Optimal Control Problem
Wan, F. Y. M., Sadovsky, A. V., & Komarova, N. L. (2010) · Studies in Applied Mathematics · doi:10.1111/j.1467-9590.2009.00476.x · Cited by 6
“There is growing biological evidence that the degree of genetic instability is high at relatively early stages of carcinogenesis, and decreases as cancer progresses [15, 16].”
BackgroundResult3D SEGMENTATION OF WHOLE CELLS AND CELL NUCLEI IN TISSUE USING DYNAMIC PROGRAMMING
McCullough, D. P., Gudla, P. R., Meaburn, K. J., Kumar, A., Kuehn, M. R., & Lockett, S. J. (2007) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi.2007.356842 · Cited by 3
Self-citationScalable Mining and Analysis of Protein-Protein Interaction Networks
Arifuzzaman, S., & Pandey, B. (2017) · IEEE Intl Conf on Dependable, Autonomic and Secure Computing, Intl Conf on Pervasive Intelligence and Computing, Intl Conf on Cloud and Big Data Computing, Intl Conf on Cyber Science and Technology Congress (DASC/PiCom/CBDCom/CyberSciTech) · doi:10.1109/dasc-picom-datacom-cyberscitec.2017.178 · Cited by 3
“It also reveals the causes of diseases– for instance, most cancers are caused by increasing interaction edge weights of oncogenes and decreasing interaction edge weights of tumor suppressor genes [12], [14].”
BackgroundMultistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Gallegos, J. R., & Liu, Y. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01402-0 · Cited by 2
Precancer in Animal Models: Sequentially Acquired or Predetermined?
Cardiff, R. D., & Borowsky, A. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6694-0_8 · Cited by 2
“In vitro molecular models of human breast cancer suggest that the major changes in breast cancer occur before the emergence of DCIS [ 42 ].”
BackgroundResultInfluential
Metadata
- Authors
- Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., Miranda, M., Krig, S., Garbe, J., Stampfer, M., Yaswen, P., Gray, J. W., & Lockett, S. J.
- Affiliations
- University of California, San Francisco (US)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Gray, Joe W
- Venue
- Nature Genetics
- Published
- 2004-08-08
- Volume
- 36
- Issue
- 9
- Pages
- 984-988
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2053300345
- Semantic Scholar
- 005930a6472117d3d08d09415087ec01d5c8ecb1
- Cited by
- 361
- References
- 30
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 8 · 2018: 17 · 2017: 15 · 2016: 19 · 2015: 19 · 2014: 14 · 2013: 24 · 2012: 24
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- U.S. Department of Health and Human Services
- Avon Foundation for Women
- Universiteit Leiden
- National Institutes of Health
- National Cancer Institute (R01CA101359, R01CA090421)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- genomic instability, telomere crisis, breast cancer progression, ductal carcinoma in situ, usual ductal hyperplasia, mammary epithelial cells, ZNF217, cell immortalization, fluorescence in situ hybridization
- MeSH terms
- Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Humans, Hyperplasia, Tumor Cells, Cultured, Ultrasonography, Telomere, In Situ Hybridization, Carcinoma, Ductal, Breast, Disease Progression, Chromosomal Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.